During a euglycemic-hyperinsulinemic clamp, insulin infusion maintains a controlled insulin level while blood glucose is kept at a controlled concentration. The amount of glucose required to maintain that condition reflects glucose disposal during insulin stimulation. Lower glucose disposal indicates reduced insulin sensitivity, making the clamp useful for detailed metabolic phenotyping and intervention research.
Insulin-mediated suppression of hepatic glucose production provides a metabolic readout distinct from glucose disposal. If insulin fails to suppress hepatic glucose production adequately, that pattern indicates diminished insulin sensitivity. Assessing both hepatic glucose production and glucose disposal therefore helps describe impaired metabolic control more completely than evaluating a single blood glucose concentration.
These approaches answer related but different questions. An oral glucose tolerance test examines glucose and insulin concentrations after a glucose challenge, whereas the euglycemic-hyperinsulinemic clamp evaluates glucose disposal while an insulin infusion maintains a controlled level. Calculated surrogate indices provide an additional approach for supporting diagnosis, phenotyping, and treatment research.
The core measurements are blood glucose and insulin concentrations, interpreted in relation to the testing condition. After an oral glucose challenge, their pattern is assessed in response to that challenge. During controlled insulin infusion, glucose concentrations and disposal are evaluated under maintained conditions. These measurements connect circulating signals with overall metabolic control.
In medicine, these assessments help identify impaired metabolic control and characterize insulin resistance in diabetes and related metabolic disorders. They also support phenotyping, meaning the description of metabolic features within a disease or participant group. In treatment research, the same approaches help evaluate whether an intervention changes insulin sensitivity or glucose regulation.
Calculated surrogate indices convert available glucose and insulin measurements into summary measures of insulin action. They can support diagnosis, metabolic phenotyping, and treatment research alongside challenge-based or infusion-based testing. Their practical value is that they organize concentration data into a form that helps characterize insulin sensitivity and impaired metabolic control across clinical or research assessments.